The Value of Vaccination Research Network (VoVRN) is pleased to announce the initiation of a grant-making cycle to fund research on the broader social and economic impacts of vaccination (BSEIV) due Aug 4 2017. See instructions here.

Gavi committed to monitoring externalities of it activities in countries, and on manufacturers and partners. To do so, we are asking the public to help identify externalities of market shaping and how to monitor them. See more here

R4D is seeking to partner with an organization based in Asia, Africa, or Eastern Europe that can provide technical and facilitation assistance for the Learning Network for Countries in Transition. EOI due 7/31/2017. See more here

Your participation in this survey is crucial in helping us develop the evidence and resources to further the field of Immunization Economics. This survey should take around 20 minutes to complete. Thank you very much for your support. Take the survey here

New analyses revealed costs distribution across budget categories and programmatic activities, and investigated variation of the cost structure by country and site characteristics. See more here

Recent workshop discussed the state of research on the broader social and economic impacts of vaccination (BSEIV), including ongoing and prospective research. Access summary and presentation materials here

Robert Steinglass, Director of the Immunization Center at JSI, delivered a keynote address during the recent workshop: Innovative Approaches to Widening and Deepening Research on the Value of Vaccination. See more here

ICAN research teams from Indonesia, Tanzania, and Vietnam discussed research questions and study designs, which aims to build capacity around generation and use of cost evidence to work toward sustainable immunization financing. See more here

Focused on capacity building in applied vaccine economics, cost-effectiveness and finance, TVEE targets audience who are current decision-makers in EPI programs, NiTAGs and partners in GAVI eligible countries. Read more here

Researchers have identified vaccination benefits that should be incorporated into economic evaluations to reflect vaccination’s full value. The article discusses data sources, methods, and research questions to be explored. See more here

Include your papers, reports, presentations, policy documents, or data sets for a systematic review of published and grey literature on the delivery costs of immunization programs in low- and middle-income countries. See more here

Leading experts in the field of vaccination research convened on April 2016 to identify barriers impeding evaluations of the economic impact of immunization to help guide investments in this area. See workshop background and summary.

Accurate information on the cost and financing of national immunization programs can be lacking. Research and a new website are designed to help governments worldwide manage their immunization programs and plan for the future. See more here

A recent issue of Health Affairs published the return on investment for vaccination in 94 low- and middle-income countries. Furthermore, an EPIC study finds that governments fund more than half of total immunization expenditures. See more here

Vaccine Volume 33, Supplement 1, Pages A1-A254 (7 May 2015): Expanding the Evidence Base to Inform Vaccine Introduction: Program Costing and Cost-effectiveness Analyses. See more here

The recent issue published, among others, papers on the return on investment, and the share of government financing of immunization program. The briefing video, audio, agenda, and slides have been posted to Health Affair's website.

PAHO / WHO: Although new vaccines are more costly than traditional ones, they are overwhelmingly cost-effective and should continue to be considered a public health "best buy." See more here.

Performance, productivity and costs of immunization programs - evidence from the EPIC studies. This panel session focuses on the productivity and cost determinants of routine immunization programs. See more here.